United States · Biopharma startup

Seres Therapeutics

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Funding reportedLast round: Post ipo debt

BiopharmaCambridge, United States

What company datasets say Seres Therapeutics raised

Funding, as reported

Reported in all$538Min dollars
Rounds10
Last roundPost ipo debt
Last round dateApr 2023
Investors listed9

Founders and team

From Seres Therapeutics's own website: 2 on the team.

  • Richard KenderExecutive Chair and Interim Chief Executive Officer
  • Chris McChalicherEVP, Chief Technology Officer

AdvisersStephen Berenson

Biopharma in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Seres Therapeutics in front of investors. Or tell us what we have wrong.

List your startupSend a correction